Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02.04 - Discussant
06:57 - 07:04 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
OA07 - What's On The Horizon for SCLC?
- 08:15 - 09:15
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Small Cell Lung Cancer/ NET
- Moderators:Christine M. Lovly
-
+
OA07.01 - Signatures of Plasticity and Immunosuppression in a Single-Cell Atlas of Human Small Cell Lung Cancer
08:15 - 08:25 | Presenter: Joseph Minhow Chan
- Abstract
Loading...
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- 14:30 - 16:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02A.04 - Discussant
14:57 - 15:04 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
MA11 - New Biological Insights for Targeted Therapies
- 18:45 - 19:45
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
-
+
MA11.06 - Multi-Omic Characterization of Lung Tumors Implicates AKT and MYC Signaling in Adenocarcinoma to Squamous Cell Transdifferentiation
19:20 - 19:25 | Presenter: Alvaro Quintanal-Villalonga
- Abstract
Loading...
-
+
MA16 - SCLC: New Targets, Biomarkers, and Systemic Therapies
- 20:00 - 21:00
- 9/13/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Small Cell Lung Cancer/ NET
-
+
MA16.03 - CRISPR Screen Reveals XPO1 as a Therapeutic Target Strongly Sensitizing to First and Second Line Therapy in Small Cell Lung Cancer
20:10 - 20:15 | Presenter: Alvaro Quintanal-Villalonga
- Abstract
Loading...
